Unlock 20% Off Global Market Reports Using Code ONLINE20 – Stay Informed on Trade Policies, Market Growth, and Key Disruptors
What Is the Current Market Size and Growth Rate of the Pharma 5.0 Market?
The pharma 5.0 market size has grown strongly in recent years. It will grow from $73.66 billion in 2024 to $78.31 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to growing investments in digital health technologies, increasing need for cost-effective drug development, rising focus on patient-centric healthcare, growing use of automation in pharmaceutical manufacturing, and increasing prevalence of chronic diseases.
The pharma 5.0 market size is expected to see strong growth in the next few years. It will grow to $98.68 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to rising investments in big data analytics and cloud computing, growing focus on sustainable and cost-efficient drug development, increasing collaboration between pharmaceutical and technology sectors, rising patient demand for personalized healthcare experiences, and growing demand for precision medicine and tailored therapies. Major trends in the forecast period include advancement in personalized medicine platforms, development of AI-driven drug discovery and manufacturing, innovation in digital therapeutics and diagnostics, advancement of IoT-enabled smart manufacturing, and development of connected health ecosystems and real-time monitoring.
Claim your free report sample now:
What Are the Key Factors Contributing to Pharma 5.0 Market Growth?
The surge in digital health technologies is expected to propel the growth of the pharmacy 5.0 market going forward. Digital health technologies refer to a broad range of tools and solutions that use digital platforms, software, and devices to support health care delivery, improve patient outcomes, and enhance the efficiency of health systems. The rise in digital health technologies is due to increasing demand for remote healthcare solutions that provide convenient, real-time access to medical services. Pharma 5.0 helps digital health technologies by enabling seamless integration of AI-driven insights, personalized medicine, and automated processes, which together improve patient monitoring, treatment accuracy, and healthcare delivery efficiency. For instance, in February 2023, according to a survey conducted by Rock Health, a US-based health technology company, between July 12 and August 22, 2022, a survey of 8,014 individuals revealed that 76% of those aged above 55 had utilized telemedicine. In total, 80% of participants indicated they had received healthcare through telemedicine at least once, marking an 8% rise from the 72% reported in 2021. Therefore, the surge in digital health technologies is driving the growth of the pharmacy 5.0 market.
What Are the Core Segments Shaping the Pharma 5.0 Market Landscape?
The pharma 5.0 market covered in this report is segmented
1) By Type: Personalized Medicine Platforms, Digital Therapeutics, Artificial Intelligence-Driven Drug Discovery, Smart Manufacturing, Artificial Intelligence-Based Diagnostics
2) By Technology: Cloud Computing, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Robotic Process Automation (RPA)
3) By Deployment Mode: On-Premise, Cloud-Based
4) By Therapeutic Area: Cardiovascular Diseases, Oncology, Infectious Diseases, Neurology, Other Therapeutic Areas
5) By End-User: Pharmaceutical And Biotech Companies, Healthcare Providers, Contract Research Organizations (CROs), Research Institutes
Subsegment:
1) By Personalized Medicine Platforms: Genomic Sequencing, Biomarker Identification, Pharmacogenomics, Patient Data Integration, Precision Drug Formulation
2) By Digital Therapeutics: Mobile Health Applications, Cognitive Behavioral Therapy (CBT) Tools, Chronic Disease Management Software, Virtual Rehabilitation Platforms, Remote Monitoring Devices
3) By Artificial Intelligence-Driven Drug Discovery: Target Identification, Molecule Screening, Predictive Toxicology, Drug Repurposing, Clinical Trial Optimization
4) By Smart Manufacturing (Digital Twins and Automation): Process Automation, Digital Twin Simulation, Predictive Maintenance, Quality Control Systems, Robotics In Manufacturing
5) By Artificial Intelligence-Based Diagnostics: Medical Imaging Analysis, Genomic Data Interpretation, Predictive Risk Modeling, Real-Time Patient Monitoring, Diagnostic Decision Support Systems
Which Emerging Trends Are Driving the Pharma 5.0 Market?
Major companies operating in the pharma 5.0 market are focusing on developing advanced solutions, such as generative artificial intelligence (AI) cloud services, to accelerate drug discovery, optimize clinical trials, enhance personalized treatment plans, and improve overall operational efficiency. Generative artificial intelligence (AI) cloud services refer to cloud-based platforms that use AI models to create new content, insights, or solutions by learning patterns from existing data. For instance, in March 2023, NVIDIA Corporation, a US-based technology company, launched BioNeMo Cloud, a revolutionary generative artificial intelligence (AI) platform designed to transform life sciences research and development. The new service was developed in collaboration with leading biotech and pharmaceutical companies, including Amgen and AstraZeneca, to deliver cutting-edge AI models for accelerated drug discovery. BioNeMo Cloud provides researchers with large language models (LLMs) tailored for biomolecular data, enabling rapid prediction of protein structures, molecular interactions, and novel drug candidates.
Which Players Dominate the Pharma 5.0 Market Landscape?
Major companies operating in the pharma 5.0 market are Pfizer Incorporated, Johnson & Johnson, Roche Holding AG, Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca Plc, Novartis AG, GSK Plc, Eli Lilly and Company, Ericsson AB, Merck KGaA, Moderna Inc., BioNTech SE, Teva Pharmaceuticals Industries Ltd., Rockwell Automation Inc., Sun Pharmaceutical Industries Ltd., 3D Systems Corporation, XtalPi Inc., Insilico Medicine Inc., and Hygenix Inc.
Get the full pharma 5.0 market report here:
What Are the Regional Insights for the Pharma 5.0 Market Forecast?
North America was the largest region in the pharma 5.0 market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma 5.0 market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
Comments
Post a Comment